Literature DB >> 1946022

Dissociative disorders in children and adolescents. A developmental perspective.

F W Putnam1.   

Abstract

Childhood and adolescent dissociative disorders are being diagnosed increasingly by mental health professionals who work with traumatized children. The identification of these conditions is hampered by the high background level of normal dissociative behavior observed in children and adolescents. An awareness of the underlying developmental processes and issues can aid in the identification of pathologic dissociation.

Entities:  

Mesh:

Year:  1991        PMID: 1946022

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  5 in total

Review 1.  Emotion Regulation Strategies as Risk Factors for Developmental Psychopathology: a Meta-analytic Review of Longitudinal Studies based on Cross-lagged Correlations and Panel Models.

Authors:  Marco Cavicchioli; Valentina Tobia; Anna Ogliari
Journal:  Res Child Adolesc Psychopathol       Date:  2022-10-08

2.  Child dissociation and the family context.

Authors:  B J Mann; S Sanders
Journal:  J Abnorm Child Psychol       Date:  1994-06

3.  Validation of the Italian version of the dissociative experience scale for adolescents and young adults.

Authors:  Concetta De Pasquale; Federica Sciacca; Zira Hichy
Journal:  Ann Gen Psychiatry       Date:  2016-11-10       Impact factor: 3.455

4.  Brain functional integration: an epidemiologic study on stress-producing dissociative phenomena.

Authors:  Raffaele Sperandeo; Vincenzo Monda; Giovanni Messina; Marco Carotenuto; Nelson Mauro Maldonato; Enrico Moretto; Elena Leone; Vincenzo De Luca; Marcellino Monda; Antonietta Messina
Journal:  Neuropsychiatr Dis Treat       Date:  2017-12-19       Impact factor: 2.570

5.  Dissociative symptomatology mediates the relation between posttraumatic stress disorder severity and alcohol-related problems.

Authors:  Herry Patel; Charlene O'Connor; Krysta Andrews; Michael Amlung; Ruth Lanius; Margaret C McKinnon
Journal:  Alcohol Clin Exp Res       Date:  2022-02       Impact factor: 3.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.